Oxford University is to test the world’s best-selling prescription medicine, adalimumab, as a treatment for Covid-19 patients, The Guardian reports, in the latest effort to repurpose existing drugs as potential coronavirus remedies.
Adalimumab, sold by AbbVie under the brand name Humira, is an anti-inflammatory drug, and studies have shown that coronavirus patients already taking this drug (usually for inflammatory bowel disease or inflammatory arthritis) have a better prognosis.